CoChat
Sign Up
Cited by 151

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion

Long, Yu, Yang, Qiyue, Xiang, Yan, Zhang, Yulu, Wan, Jinyan, Liu, Songyu, Li, Nan, Peng, Wei·2020·Pharmacological Research
DOI 10.1016/j.phrs.2020.104795
Open this paper in CoChat — free account

Abstract

Cerebral ischemia reperfusion injury (CIRI), one of the major causes of death from stroke in the world, not only causes tremendous damage to human health, but also brings heavy economic burden to society. Current available treatments for CIRI, including mechanical therapies and drug therapies, are often accompanied by significant side-effects. Therefore, it is necessary to discovery new strategies for treating CIRI. Many studies have confirmed that the herbal medicine has the advantages of abundant resources, good curative effect and little side effects, which can be used as potential drug for treatment of CIRI through multiple targets. It's known that oral administration commonly has low bioavailability, and injection administration is inconvenient and unsafe. Many drugs can't delivery to brain through routine pathways due to the blood-brain-barrier (BBB). Interestingly, increasing evidences have suggested the nasal administration is a potential direct route to transport drug into brain avoiding the BBB and has the characteristics of high bioavailability for treating brain diseases. Therefore, intranasal administration can be treated as an alternative way to treat brain diseases. In the present review, effective methods to treat CIRI by using active ingredients derived from herbal medicine through nose to brain drug delivery (NBDD) are updated and discussed, and some related pharmacological mechanisms have also been emphasized. Our present study would be beneficial for the f…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2020.104795

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 211

  1. GBD, 2017, Lancet, 390, 1260, 10.1016/S0140-6736(17)32130-X · DOI · Paper page
  2. Randolph, 2016, Ischemic stroke, Workplace Health Saf., 64, 444, 10.1177/2165079916665400 · DOI
  3. Ou, 2017, MiR-375 attenuates injury of cerebral ischemia/reperfusion via targeting Ctgf, Biosci. Rep., 37, 10.1042/BSR20171242 · DOI
  4. Zhang, 2016, Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms, Eur. J. Pharmacol., 771, 145, 10.1016/j.ejphar.2015.12.003 · DOI · Paper page
  5. Taoufik, 2008, Ischemic neuronal damage, Curr. Pharm. Des., 14, 3565, 10.2174/138161208786848748 · DOI
  6. Guo, 2019, Natural compound methyl protodioscin protects rat brain from ischemia/reperfusion injury through regulation of Mul1/SOD2 pathway, Eur. J. Pharmacol., 849, 50, 10.1016/j.ejphar.2019.01.057 · DOI
  7. Doyle, 2008, Mechanisms of ischemic brain damage, Neuropharmacology, 55, 310, 10.1016/j.neuropharm.2008.01.005 · DOI
  8. Hentia, 2018, An overview of protective strategies against ischemia/reperfusion injury: the role of hyperbaric oxygen preconditioning, Brain Behav., 8, 10.1002/brb3.959 · DOI
  9. Wang, 2019, Electroacupuncture ameliorates neuronal injury by Pink1/Parkin-mediated mitophagy clearance in cerebral ischemia-reperfusion, Nitric Oxide, 91, 23, 10.1016/j.niox.2019.07.004 · DOI
  10. Tsivgoulis, 2018, Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions, Stroke, 49, 232, 10.1161/STROKEAHA.117.019261 · DOI
  11. Zhao, 2011, Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model, J. Nutr. Biochem., 22, 929, 10.1016/j.jnutbio.2010.07.014 · DOI
  12. Savitz, 2017, Reconsidering neuroprotection in the reperfusion era, Stroke, 48, 3413, 10.1161/STROKEAHA.117.017283 · DOI
  13. Liu, 2017, Effect of ulinastatin on the permeability of the blood-brain barrier on rats with global cerebral ischemia/reperfusion injury as assessed by MRI, Biomed. Pharmacother., 85, 412, 10.1016/j.biopha.2016.11.044 · DOI
  14. Li, 2017, Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia/reperfusion injury, Neurol. Res., 39, 367, 10.1080/01616412.2017.1286541 · DOI
  15. Kwon, 2015, Nafamostat mesilate attenuates transient focal ischemia/reperfusion-induced brain injury via the inhibition of endoplasmic reticulum stress, Brain Res., 1627, 12, 10.1016/j.brainres.2015.09.013 · DOI
  16. Chen, 2014, Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition, Sci. Rep., 4, 5531, 10.1038/srep05531 · DOI
  17. Izuma, 2018, Thrombolysis with rt-PA under rivaroxaban anticoagulation in a hypertensive rat model of intraluminal middle cerebral artery occlusion, J. Stroke Cerebrovasc. Dis., 27, 2761, 10.1016/j.jstrokecerebrovasdis.2018.06.003 · DOI
  18. Morihara, 2017, Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR‐1 and PAR‐2, J. Neurosci. Res., 95, 1818, 10.1002/jnr.24013 · DOI
  19. Zheng, 2006, Inhibitory action of propyl gallate on the activation of SAPK/JNK and p38MAPK induced by cerebral ischemia-reperfusion in rats, Acta Pharm. Sin. B, 41, 548
  20. Berekashvili, 2018, Safety and feasibility of argatroban, recombinant tissue plasminogen activator, and intra-arterial therapy in stroke (ARTSS-IA Study), J. Stroke Cerebrovasc. Dis., 27, 3647, 10.1016/j.jstrokecerebrovasdis.2018.08.036 · DOI
  21. Xue, 2017, Calcium-sensing receptor antagonist NPS2390 attenuates neuronal apoptosis though intrinsic pathway following traumatic brain injury in rats, Biochem. Biophys. Res. Commun., 486, 589, 10.1016/j.bbrc.2017.03.097 · DOI
  22. Wada, 2014, Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator, J. Neurol. Sci., 345, 106, 10.1016/j.jns.2014.07.018 · DOI
  23. Huang, 2017, S-oxiracetam protect against ischemic stroke via alleviating blood brain barrier dysfunction in rats, Eur. J. Pharm. Sci., 109, 40, 10.1016/j.ejps.2017.07.029 · DOI
  24. Llorente, 2013, Unfolded protein response to global ischemia following 48 h of reperfusion in the rat brain: the effect of age and meloxicam, J. Neurochem., 127, 701, 10.1111/jnc.12337 · DOI
  25. Lu, 2014, Distribution of α-asarone in brain following three different routes of administration in rats, Eur. J. Pharm. Sci., 63, 63, 10.1016/j.ejps.2014.06.006 · DOI
  26. Dobrivojević, 2015, Involvement of bradykinin in brain edema development after ischemic stroke, Pflugers Arch., 467, 201, 10.1007/s00424-014-1519-x · DOI
  27. Li, 2016, Multi-target strategy and experimental studies of traditional Chinese medicine for alzheimer’s disease therapy, Curr. Top. Med. Chem., 16, 537, 10.2174/1568026615666150813144003 · DOI
  28. Zhang, 2019, Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts, Biomed. Pharmacother., 118, 10.1016/j.biopha.2019.109367 · DOI
  29. Sun, 2015, Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage, Acta Pharm. Sin. B, 5, 8, 10.1016/j.apsb.2014.11.002 · DOI
  30. Gao, 2015, Ligustrazine monomer against cerebral ischemia/reperfusion injury, Neural Regen. Res., 10, 832, 10.4103/1673-5374.156991 · DOI
  31. Miyake, 2015, The blood-brain barrier and nasal drug delivery to the central nervous system, Am. J. Rhinol. Allergy, 29, 124, 10.2500/ajra.2015.29.4149 · DOI · Paper page
  32. Kapoor, 2016, A review of intranasal formulations for the treatment of seizure emergencies, J. Control Release., 237, 147, 10.1016/j.jconrel.2016.07.001 · DOI
  33. Vyas, 2005, Intranasal drug delivery for brain targeting, Curr. Drug Deliv., 2, 165, 10.2174/1567201053586047 · DOI
  34. Battaglia, 2018, Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery, Expert Opin. Drug Deliv., 15, 369, 10.1080/17425247.2018.1429401 · DOI
  35. Lochhead, 2012, Intranasal delivery of biologics to the central nervous system, Adv. Drug Deliv. Rev., 64, 614, 10.1016/j.addr.2011.11.002 · DOI · Paper page
  36. Johanson, 2016, Merging transport data for choroid plexus with blood-brain barrier to model CNS homeostasis and disease more effectively, CNS Neurol. Disord. Drug Targets, 15, 1151, 10.2174/1871527315666160915120758 · DOI
  37. Grassin-Delyle, 2012, Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids, Pharmacol. Ther., 134, 366, 10.1016/j.pharmthera.2012.03.003 · DOI · Paper page
  38. Selvaraj, 2018, Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting, Artif. Cells Nanomed. Biotechnol., 46, 2088
  39. John, 2014, Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis, MBio, 5
  40. Ma, 2008, Trigeminal nerve pathway to brain following intranasal administration of transforming growth factor beta 1, Med. J. Chin. PLA., 33, 219
  41. John, 2016, Burkholderia pseudomallei rapidly infects the brain stem and spinal cord via the trigeminal nerve after intranasal inoculation, Infect. Immun., 84, 2681, 10.1128/IAI.00361-16 · DOI
  42. Hanson, 2007, Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS, J. Neuroimmune Pharmacol., 2, 81, 10.1007/s11481-006-9039-x · DOI
  43. Miyamoto, 2001, Effect of poly-L-arginine on the nasal absorption of FTIR-dextran of different molecular weights and recombinant human granulocyte colony stimulating factor (RHG-SF) in rats, Int. J. Pharm., 226, 127, 10.1016/S0378-5173(01)00797-9 · DOI
  44. Brightman, 1976, The morphological approach to the study of normal and abnormal brain permeability, Adv. Exp. Med. Biol., 69, 41, 10.1007/978-1-4684-3264-0_4 · DOI
  45. Chatterjee, 2017, Nose to brain drug delivery: a recent update, J. Formul. Sci. Bioavailab., 1
  46. Wu, 2008, From nose to brain: understanding transport capacity and transport rate of drugs, Expert Opin. Drug Deliv., 5, 1159, 10.1517/17425247.5.10.1159 · DOI
  47. Garg, 2015, Current nanotechnological approaches for an effective delivery of bioactive drug molecules to overcome drug resistance tuberculosis, Curr. Pharm. Des., 21, 3076, 10.2174/1381612821666150531163254 · DOI
  48. Dai, 2018, Neuroprotective effect of baicalin on focal cerebral ischemia in rats, Neural Regen. Res., 13, 2129, 10.4103/1673-5374.241464 · DOI
  49. Zhou, 2014, Baicalin attenuates brain edema in a rat model of intracerebral hemorrhage, Inflammation, 37, 107, 10.1007/s10753-013-9717-9 · DOI
  50. Xue, 2010, Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation, Biochem. Biophys. Res. Commun., 403, 398, 10.1016/j.bbrc.2010.11.042 · DOI
  51. Li, 2011, Evaluation of brain-targeting of nasal baicalin-phospholipid complex in situ gel, Chin. Pharm. J., 46, 1254
  52. Li, 2018, Preparation, characterization, pharmacokinetics and biodistribution of baicalin-loaded liposome on cerebral ischemia-reperfusion after iv administration in rats, Molecules, 23, 1747, 10.3390/molecules23071747 · DOI
  53. Xiang, 2020, Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration, Brain Res., 1726, 10.1016/j.brainres.2019.146503 · DOI
  54. Jiang, 2017, Breviscapine reduces neuronal injury caused by traumatic brain injury insult: partly associated with suppression of interleukin-6 expression, Neural Regen. Res., 12, 90, 10.4103/1673-5374.198990 · DOI
  55. Tang, 2005, Protective effects of Breviscapine injection against focal cerebral ischemia-reperfusion injury in rats, Chin. J. Clin. Rehab., 9, 243
  56. Guo, 2014, Therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemia/reperfusion injury in rats, J. Ethnopharmacol., 151, 660, 10.1016/j.jep.2013.11.026 · DOI
  57. Cao, 2017, Mechanism of Breviscapine on cerebral ischemia reperfusion injury of rats by CYP4A pathway, chin, J. Exp. Tradit. Med. Form., 23, 101
  58. Zhang, 2017, Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra, Biomed. Pharmacother., 90, 69, 10.1016/j.biopha.2017.03.039 · DOI
  59. Shi, 2009, Comparative study on the effects of breviscapine on experimental cerebral ischemia in rats, Chin. Tradit. Herbal Drugs., 40, 274
  60. Tao, 2013, HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia–reperfusion injury in rats, Naunyn Schmiedebergs Arch. Pharmacol., 386, 61, 10.1007/s00210-012-0804-5 · DOI
  61. Zhou, 2014, Puerarin protects brain tissue against cerebral ischemia/reperfusion injury by inhibiting the inflammatory response, Neural Regen. Res., 9, 2074, 10.4103/1673-5374.147934 · DOI
  62. Ling, 2018, Synergistic effects of salvianolic acid B and puerarin on cerebral ischemia reperfusion injury, Molecules, 23, 564, 10.3390/molecules23030564 · DOI
  63. Wang, 2014, Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition, Neuropharmacology, 79, 282, 10.1016/j.neuropharm.2013.12.004 · DOI
  64. Chen, 2018, Effects of Puerarin on the expression of P-STAT3 and P53 in Hippocampus tissue of cerebral ischemia-reperfusion injury model rats, J. Hunan Univ. Chin. Med., 38, 36
  65. Xu, 2005, The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats, Planta Med., 71, 585, 10.1055/s-2005-871261 · DOI
  66. Chen, 2011, Study on pharmacokinetics of puerarin in rats following different methods of administration of Tongqiao Sanyu prescription, Chin. J. Chin. Mater. Med., 36, 2347, 10.1007/s10856-011-4401-9 · DOI
  67. Yu, 2011, Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion, J. Pharm. Sci., 100, 933, 10.1002/jps.22333 · DOI
  68. Li, 2013, Bioavailability and brain-targeting of puerarin by different administration routes in rats, J. Drug Deliv. Sci. Technol., 23, 583, 10.1016/S1773-2247(13)50088-8 · DOI
  69. Zhang, 2016, Puerarin transport across a Calu-3 cell monolayer–an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol, Drug Des. Devel. Ther., 10, 2227, 10.2147/DDDT.S110247 · DOI
  70. Yang, 2018, Nose-to-brain delivery: puerarin uptake on olfactory ensheathing cells and transport on Calu-3 cells, Chin. J. Trad. Chin. Med. Pharm., 33, 2159
  71. Pei, 2016, Quercetin ameliorates ischemia/reperfusion-induced cognitive deficits by inhibiting ASK1/JNK3/caspase-3 by enhancing the Akt signaling pathway, Biochem. Biophys. Res. Commun., 478, 199, 10.1016/j.bbrc.2016.07.068 · DOI
  72. Chirumbolo, 2019, Quercetin Might Promote Autophagy in a Middle Cerebral Artery Occlusion-Mediated Ischemia Model: Comments on Fawad-Ali Shah et al, Neurochem. Res., 44, 297, 10.1007/s11064-018-2692-7 · DOI
  73. Ahmad, 2018, Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia, Artif. Cells Nanomed. Biotechnol., 46, 717, 10.1080/21691401.2017.1337024 · DOI
  74. Guo, 1983, Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases, Planta Med., 47, 89, 10.1055/s-2007-969959 · DOI
  75. Tan, 2015, Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion, Exp. Ther. Med., 1757, 10.3892/etm.2015.2365 · DOI
  76. Liu, 2013, Influence of nasal tetramethylpyrazine phosphate pH-Sensitive in situ gel on amino acid content in rats brain of acute cerebral ischemia model, Chin. J. Mod. Appl. Pharm., 30, 929
  77. Li, 2008, Studies on brain pharmacokineties of tetramethylpyrazine hydrochloride after intranasal administration in rats, Chin. Pharm. J., 43, 452
  78. Meng, 2014, Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration, Acta Pharm. Sin. B, 4, 74, 10.1016/j.apsb.2013.12.009 · DOI
  79. Liu, 2012, Comparison of the brain pharmacokinetics of nasal tetramethylpyrazine phosphate pH-sensitive in situ gel in normal rats and model rats, Acta Pharm. Sin. B, 47, 677
  80. Ding, 2012, Research progress in analysis methods and pharmacological effects of berberine, Chin. J. Pharm. Anal, 3, 1296
  81. Wang, 2019, Coptidis Rhizoma: A review of its traditional uses, botany, phytochemistry, pharmacology, toxicology, Pharm. Biol., 57, 193, 10.1080/13880209.2019.1577466 · DOI
  82. Balmukunda, 2007, Plasma and hippocampal pharmacokinetics of berberine after intravenous or intranasal administration in rats, Pharm. Biotechnol., 14, 348
  83. Yang, 2018, Berberine ameliorates MCAO induced cerebral Ischemia/Reperfusion injury via activation of the BDNF–TrkB–PI3K/Akt signaling pathway, Neurochem. Res., 43, 702, 10.1007/s11064-018-2472-4 · DOI
  84. Pang, 2018, Effect of berberine against cerebral ischemia and reperfusion involving in the methylation of PPARγ promoter, J. Chin. Pharmac. Sci., 27, 170, 10.5246/jcps.2018.03.018 · DOI
  85. Liu, 2018, Effect of Berberine on angiogenesis and HIF-1α/VEGF signal transduction pathway in rats with cerebral ischemia-reperfusion injury, J. Coll. Physicians Surg. Pak., 28, 753
  86. Jardim, 2018, Resveratrol and brain mitochondria: a review, Mol. Neurobiol., 55, 2085, 10.1007/s12035-017-0448-z · DOI
  87. Peng, 2013, Botany, Phytochemistry, Pharmacology, and Potential Application of Polygonum Cuspidatum Sieb.et Zucc.: A Review, J. Ethnopharmacol., 148, 729, 10.1016/j.jep.2013.05.007 · DOI
  88. Das, 2007, Anti-inflammatory responses of resveratrol, Inflamm. Allergy Drug Targets, 6, 168, 10.2174/187152807781696464 · DOI
  89. Xia, 2017, Antioxidant effects of resveratrol in the cardiovascular system, Br. J. Pharmacol., 174, 1633, 10.1111/bph.13492 · DOI
  90. Kraus, 2019, Resveratrol directly controls the activity of neuronal ryanodine receptors at the single-channel level, Mol. Neurobiol., 57, 422, 10.1007/s12035-019-01705-7 · DOI
  91. He, 2017, Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction, Int. Immunopharmacol., 50, 208, 10.1016/j.intimp.2017.06.029 · DOI
  92. Abdel-Aleem, 2016, Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway, Arch. Physiol. Biochem., 122, 200, 10.1080/13813455.2016.1182190 · DOI
  93. Chang, 2018, Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats, J. Neuroimmunol., 315, 9, 10.1016/j.jneuroim.2017.11.015 · DOI
  94. Pandareesh, 2015, Bioavailability of dietary polyphenols: factors contributing to their clinical application in CNS diseases, Neurochem. Int., 89, 198, 10.1016/j.neuint.2015.07.003 · DOI
  95. Hao, 2016, Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery, Colloids Surf. B Biointerfaces, 147, 376, 10.1016/j.colsurfb.2016.08.011 · DOI
  96. Wang, 2016, Salvianolic acid B ameliorates cerebral ischemia/reperfusion injury through inhibiting TLR4/MyD88 signaling pathway, Inflammation, 39, 1503, 10.1007/s10753-016-0384-5 · DOI
  97. Fan, 2018, Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury, Brain Res., 679, 125, 10.1016/j.brainres.2017.11.027 · DOI
  98. Xu, 2017, Neuroprotective effect of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-κB pathway associated with suppression of platelets activation and neuroinflammation, Brain Res., 1661, 37, 10.1016/j.brainres.2017.02.011 · DOI
  99. Du, 2017, Study on nasal absorption in situ and blood-brain barrier cells absorption of SalB-LCN in vitro, Chin. J. Tradit. Chin. Med. Pharm., 32, 3140
  100. Ju, 2017, Effect of salvianolic acid B by intranasal administration on cognitive function and neurogenesis of cerebral ischemia rats, Chin. Tradit. Herbal Drugs., 48, 2481
  101. Nabavi, 2015, Curcumin: a natural product for diabetes and its complications, Curr. Top. Med. Chem., 15, 2445, 10.2174/1568026615666150619142519 · DOI
  102. Pluta, 2018, Neuroprotective and neurological/cognitive enhancement effects of curcumin after brain ischemia injury with Alzheimer’s disease phenotype, Int. J. Mol. Sci., 19, 4002, 10.3390/ijms19124002 · DOI
  103. Zhang, 2018, Curcumin attenuates cerebral ischemia injury in Sprague–Dawley rats and PC12 cells by suppressing overactivated autophagy, J. Photochem. Photobiol. B, 184, 1, 10.1016/j.jphotobiol.2018.05.010 · DOI
  104. Lei, 2010, Effects of curcumin on inflammatory reaction and blood-brain barrier permeability in rats following cerebral ischemic injury, Chin. Pharmacol. Bull., 26, 120
  105. Vaz, 2017, Cristiana Lima dora, development of nasal lipid nanocarriers containing curcumin for brain targeting, J. Alzheimers Dis., 59, 961, 10.3233/JAD-160355 · DOI
  106. Subhashini, 2013, Intranasal curcumin and its evaluation in murine model of asthma, Int. Immunopharmacol., 17, 733, 10.1016/j.intimp.2013.08.008 · DOI
  107. Long, 2018, Klotho upregulation contributes to the neuroprotection of ligustilide against cerebral ischemic injury in mice, Eur. J. Pharmacol., 820, 198, 10.1016/j.ejphar.2017.12.019 · DOI
  108. Yang, 2012, Advances in studies on pharmacological functions of Ligustilide and their mechanisms, Chin. Herbal Med., 4, 26
  109. Kuang, 2006, Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice, Brain Res., 1102, 145, 10.1016/j.brainres.2006.04.110 · DOI
  110. Zhang, 2016, (Z)-ligustilide increases ferroportin1 expression and ferritin content in ischemic SH-SY5Y cells, Eur. J. Pharmacol., 792, 48, 10.1016/j.ejphar.2016.10.029 · DOI
  111. Kuang, 2014, Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling, Free Radic. Biol. Med., 71, 165, 10.1016/j.freeradbiomed.2014.03.028 · DOI
  112. Guo, 2013, Analgesic activity of DaChuanXiong Fang after itranasal administration and its potential active components in vivo, J. Ethnopharmacol., 150, 649, 10.1016/j.jep.2013.09.020 · DOI
  113. Wu, 2016, Effect of cimicifugoside H-1 on amino acid neurotransmitters in striatum of rats with cerebral ischemia, Chin. J. Pathophysiol., 32, 831
  114. Wu, 2016, Feasibility of nasal brain targeted drug delivery through the nose-brain channel in the nasal olfactory region using cimicifugoside H-1, J. Clin. Rehabil. Tis. Eng. Res., 20, 688
  115. Song, 2014, Geniposide plays an anti-inflammatory role via regulating TLR4 and downstream signaling pathways in lipopolysaccharide-induced mastitis in mice, Inflammation, 37, 1588, 10.1007/s10753-014-9885-2 · DOI
  116. Li, 2019, Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system, Eur. J. Pharmacol., 854, 224, 10.1016/j.ejphar.2019.04.021 · DOI
  117. Shen, 2017, Investigate mechanism of Dioscin and Geniposide on inflammatory of cerebral ischemia and reperfusion injury at different time points of acute phase in rats, Shaanxi J. Tradit. Chin. Med., 38, 531
  118. Wu, 2019, Network pharmacology identification of mechanisms of cerebral ischemia injury amelioration by Baicalin and Geniposide, Eur. J. Pharmacol., 859, 10.1016/j.ejphar.2019.172484 · DOI
  119. Lu, 2012, Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice, Int. J. Mol. Sci., 13, 14127, 10.3390/ijms131114127 · DOI
  120. Lu, 2011, Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration, J. Zhejiang Univ. Sci. B, 12, 143, 10.1631/jzus.B1000121 · DOI
  121. Chen, 2014, Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer, PLoS One, 9
  122. Jiang, 2016, Review on mechanisms of Panax notoginseng saponins against ischemia-reperfusion injury, Chin. Archi. Tradit. Chin. Med., 34, 267
  123. Tang, 2010, Effect of Panax notoginseng saponins on extracellular matrix damage and oxidative stress after cerebral ischemia - reperfusion in mice, Chin. Archi. Tradit. Chin. Med., 28, 2327
  124. Tang, 2011, Neuroprotective role of Panax notoginseng saponins on cerebral ischemia-reperfusion injury in rats, Chin. J. Exp. Tradi.t Med. Formul., 17, 210
  125. Li, 2009, Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion, J. Ethnopharmacol., 121, 412, 10.1016/j.jep.2008.10.042 · DOI
  126. Hu, 2018, Panax notoginseng saponins protect cerebral microvascular endothelial cells against oxygen-glucose Deprivation/Reperfusion-Induced barrier dysfunction via activation of PI3K/Akt/Nrf2 antioxidant signaling pathway, Molecules, 23, 10.3390/molecules23112781 · DOI
  127. Wu, 2019, Panax notoginseng saponins ameliorate leukocyte adherence and cerebrovascular endothelial barrier breakdown upon ischemia-reperfusion in mice, J. Vasc. Res., 56, 1, 10.1159/000494935 · DOI
  128. Han, 2006, Mechanism of oral absorption of panaxnotoginseng saponins, Acta. Pharm. Sin., 41, 498
  129. Shen, 2004, Panax notoginseng saponin liposomes: characterization of pharmaceutics and pharmacokinetics on pulmonary instillation in rats, Chin. Tradit. Herbal Drugs., 35, 745
  130. Xu, 2003, Studies on formulations of Panax notoginsenosides for intranasal administration, Acta. Pharm. Sin., 38, 859
  131. Ding, 2015, W/O nanoemulsion-based intranasal drug delivery system of Panax notoginseng saponins for brain targeting, J. Control. Release, 213, e11, 10.1016/j.jconrel.2015.05.014 · DOI
  132. Liu, 2018, Ginsenoside Rb1 administration attenuates focal cerebral ischemic reperfusion injury through inhibition of HMGB1 and inflammation signals, Exp. Ther. Med., 16, 3020
  133. Cheng, 2019, Neuroprotective effects of ginsenosides against cerebral ischemia, Molecules, 24, 1102, 10.3390/molecules24061102 · DOI
  134. Zheng, 2019, Ginsenoside Rg1 attenuates protein aggregation and inflammatory response following cerebral ischemia and reperfusion injury, Eur. J. Pharmacol., 853, 65, 10.1016/j.ejphar.2019.02.018 · DOI
  135. Chu, 2019, Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway, Acta Pharmacol. Sin., 40, 13, 10.1038/s41401-018-0154-z · DOI
  136. Cao, 2015, Pharmacokinetics and brain distribution studies of ginsenoside Rd to rats via intranasal administration by LC-MS/MS, Anal. Methods, 7, 8809, 10.1039/C5AY01750E · DOI
  137. Long, 2019, Gastrodin attenuates neuroinflammation in DOI-induce Tourette syndrome in rats, J. Biochem. Mol.Toxicol., 33, 10.1002/jbt.22302 · DOI
  138. Nie, 2010, Protective effects of gastrodine on focal cerebral ischemia reperfusion injury in rats, West China J. Pharm. Sci., 25, 423
  139. Yang, 2018, The therapeutic effects of novel gastrodin derivative on cerebral ischemia / reperfusion injury in rats and safety evaluation, Nat. Prod. Res. Dev., 30, 1427
  140. Illum, 2003, Nasal drug delivery-possibilities, problems and solutions, J. Control. Release, 87, 187, 10.1016/S0168-3659(02)00363-2 · DOI
  141. Cai, 2008, Brain targeting of gastrodin nasal in situ gel, J. Sichuan Univ. (Med. Sci. Ed.), 39, 438
  142. Shi, 2017, Study of nasal absorption characteristics of Gastrodin, Chin. J. Mod. Appl. Pharm., 34, 311
  143. Pan, 2018, Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification, Drug Deliv. Transl. Res., 8, 83, 10.1007/s13346-017-0438-8 · DOI
  144. Lu, 2014, Distribution of α-asarone in brain following three different routes of administration in rats, Eur. J. Pharm. Sci., 63, 63, 10.1016/j.ejps.2014.06.006 · DOI
  145. Lu, 2017, Pharmacokinetics of α-asarone after intranasal and intravenous administration with PLA-α-asarone nanoparticles, China J. Chin. Mater. Med., 42, 2366
  146. Yang, 2013, Beta-asarone, a major component of Acorus tatarinowii Schott, attenuates focal cerebral ischemia induced by middle cerebral artery occlusion in rats, BMC Complement. Altern. Med., 13, 236, 10.1186/1472-6882-13-236 · DOI
  147. Liu, 2012, Beta-asarone attenuates ischemia-reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1, Eur. J. Pharmacol., 680, 34, 10.1016/j.ejphar.2012.01.016 · DOI
  148. Zhang, 2016, Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms, Eur. J. Pharmacol., 771, 145, 10.1016/j.ejphar.2015.12.003 · DOI · Paper page
  149. Zhan, 2005, Effects of isoliquiritigenin on cognition dysfunction and brain energy metabolism following repeated cerebral ischemia-reperfusion in mice, Chin. Pharmacol. Bull., 21, 213
  150. Liang, 2014, Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway, J. Neurol. Sci., 344, 100, 10.1016/j.jns.2014.06.033 · DOI
  151. Lv, 2015, Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway, Eur. J. Pharmacol., 769, 324, 10.1016/j.ejphar.2015.11.036 · DOI
  152. Deng, 2018, Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: a PET study using 18F-fuorodeoxyglucose, Eur. J. Pharmacol., 825, 119, 10.1016/j.ejphar.2018.02.011 · DOI
  153. Shan, 2010, Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits, BMC Neurosci., 11, 98, 10.1186/1471-2202-11-98 · DOI
  154. Ramagiri, 2016, Neuroprotective effect of hydroxy safflor yellow A against cerebral ischemia-reperfusion injury in rats: putative role of Mptp, J. Basic Clin. Physiol. Pharmacol., 27, 1, 10.1515/jbcpp-2015-0021 · DOI
  155. Zhang, 2017, Paeoniflorin attenuates cerebral ischemia-induced injury by regulating Ca2+/CaMKII/CREB signaling pathway, Molecules, 22, 10.3390/molecules22030359 · DOI
  156. Liu, 2012, Hyperoside protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via nitric oxide signal pathway, Brain Res., 1469, 164, 10.1016/j.brainres.2012.06.044 · DOI
  157. Guo, 2012, Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats, J. Ethnopharmacol., 144, 768, 10.1016/j.jep.2012.09.056 · DOI
  158. Guo, 2017, The role of TRPC6 in the neuroprotection of calycosin against cerebral ischemic injury, Sci. Rep., 7, 3039, 10.1038/s41598-017-03404-6 · DOI
  159. Wang, 2014, Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats, J. Neurol. Sci., 339, 144, 10.1016/j.jns.2014.02.002 · DOI
  160. Wang, 2018, Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats, Cell. Physiol. Biochem., 45, 537, 10.1159/000487031 · DOI
  161. Liu, 2018, Rutin attenuates cerebral ischemia/reperfusion injury in ovariectomized rats via estrogen receptor-mediated BDNF-TrkB and NGF-TrkA signaling, Biochem. Cell Biol., 96, 672, 10.1139/bcb-2017-0209 · DOI
  162. Khan, 2009, Rutin protects the neural damage induced by transient focal ischemia in rats, Brain Res., 1292, 123, 10.1016/j.brainres.2009.07.026 · DOI
  163. Wang, 2015, Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice, Phytomedicine, 22, 379, 10.1016/j.phymed.2015.01.009 · DOI
  164. Cui, 2019, Vitexin protects against ischemia/reperfusion-induced brain endothelial permeability, Eur. J. Pharmacol., 853, 210, 10.1016/j.ejphar.2019.03.015 · DOI
  165. Guo, 2008, Protective effects of total flavones of rhododendra on cerebral ischemia reperfusion injury, Am. J. Chin. Med., 36, 343, 10.1142/S0192415X08005813 · DOI
  166. Han, 2018, Total flavone of Rhododendron Improves cerebral ischemia injury by activating vascular TRPV4 to induce endothelium-derived hyperpolarizing factor-mediated responses, Evid-Based. Compl. Alt.
  167. Sun, 2018, Total flavones of Rhododendron simsii Planch flower protect isolated rat heart from ischaemia-reperfusion injury and its mechanism of UTR-RhoA-ROCK pathway inhibition, J. Pharm. Pharmacol., 70, 1713, 10.1111/jphp.13016 · DOI
  168. Yu, 2009, Protective effects of total flavones of rhododendra against global cerebral ischemia reperfusion injury, Am. J. Chin. Med., 37, 877, 10.1142/S0192415X09007284 · DOI
  169. Pang, 2018, Apigenin protects the brain against Ischemia/Reperfusion injury via Caveolin-1/VEGF in vitro and in vivo, Oxid. Med. Cell. Longev.
  170. Yang, 2016, Therapeutic effect analysis of Sinomenine on rat cerebral ischemia–Reperfusion injury, J. Stroke Cerebrovasc. Dis., 25, 1263, 10.1016/j.jstrokecerebrovasdis.2016.02.023 · DOI
  171. Li, 2012, Protective effects of Sinomenine on mice brain cells after ischemia-reperfusion injury, Med. Res. Educ., 29, 14
  172. Zhou, 2009, Effect of Sinomenine on expression of Bcl-2 and Bax following cerebral ischemic reperfusion injury in diabetic rats, J. Emerg. Tradit. Chin. Med., 18, 763
  173. Chen, 2010, Effects of Matrine on inflammatory cytokines for rats with cerebral ischemia reperfusion injury, J. Emerg. Tradit. Chin. Med., 19, 2098
  174. Zhao, 2015, Matrine attenuates focal cerebral ischemic injury by improving antioxidant activity and inhibiting apoptosis in mice, Int. J. Mol. Med., 36, 633, 10.3892/ijmm.2015.2260 · DOI
  175. Chen, 2012, Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats, PLoS One, 7, 10.1371/journal.pone.0040165 · DOI
  176. Tang, 2014, Protective effect of tanshinone IIA on the brain and its therapeutic time window in rat models of cerebral ischemia-reperfusion, Exp. Ther. Med., 8, 1616, 10.3892/etm.2014.1936 · DOI
  177. Li, 2015, Studies on the active constituents in radix salviae miltiorrhizae and their protective effects on cerebral ischemia reperfusion injury and its mechanism, Pharmacogn. Mag., 11, 69, 10.4103/0973-1296.149706 · DOI
  178. Cai, 2017, Tanshinone IIA elicits neuroprotective effect through activating the nuclear factor erythroid 2-Related factor-dependent antioxidant response, Rejuvenation Res., 20, 286, 10.1089/rej.2016.1912 · DOI
  179. Wen, 2016, Tanshinone IIA increases levels of NeuN, protein disulfide isomerase, and Na+/K+-ATPase and decreases evidence of microglial activation after cerebral ischemic injury, Neuroreport, 27, 435, 10.1097/WNR.0000000000000559 · DOI
  180. Zhang, 2016, Ilexonin a promotes neuronal proliferation and regeneration via activation of the canonical wnt signaling pathway after cerebral ischemia reperfusion in rats, Evid. Complement. Alternat. Med., 2016
  181. Xu, 2016, Neuroprotective effects of Ilexonin A following transient focal cerebral ischemia in rats, Mol. Med. Rep., 13, 957, 10.3892/mmr.2016.4921 · DOI
  182. Guo, 2010, Anti-inflammation effects of picroside 2 in cerebral ischemic injury rats, Behav. Brain Funct., 6, 43, 10.1186/1744-9081-6-43 · DOI · Paper page
  183. Li, 2018, Picroside II exerts a neuroprotective effect by inhibiting mPTP permeability and EndoG release after cerebral Ischemia/Reperfusion injury in rats, J. Mol. Neurosci., 64, 144, 10.1007/s12031-017-1012-z · DOI
  184. Wang, 2015, Picroside II inhibits the MEK-ERK1/2-COX2 signal pathway to prevent cerebral ischemic injury in rats, J. Mol. Neurosci., 57, 335, 10.1007/s12031-015-0623-5 · DOI · Paper page
  185. Zhang, 2017, Picroside II exerts a neuroprotective effect by inhibiting the mitochondria cytochrome C signal pathway following ischemia reperfusion injury in rats, J. Mol. Neurosci., 61, 267, 10.1007/s12031-016-0870-0 · DOI
  186. Liu, 2016, Morroniside promotes angiogenesis and further improves microvascular circulation after focal cerebral ischemia/reperfusion, Brain Res, Bull., 127, 111
  187. Wang, 2010, Neuroprotective effect of morroniside on focal cerebral ischemia in rats, Brain Res. Bull., 83, 196, 10.1016/j.brainresbull.2010.07.003 · DOI
  188. Zeng, 2018, Morroniside protects against cerebral ischemia/reperfusion injury by inhibiting neuron apoptosis and MMP2/9 expression, Exp. Ther. Med., 16, 2229
  189. Gu, 2012, Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury, Eur. J. Pharm. Sci., 47, 652, 10.1016/j.ejps.2012.07.016 · DOI
  190. Zheng, 2018, Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitro, Neural Regen, Res., 13, 1204
  191. Ma, 2012, Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats, J. Nat. Med., 66, 25, 10.1007/s11418-011-0545-7 · DOI
  192. Liu, 2019, Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo, Cell Stress Chaperones, 24, 441, 10.1007/s12192-019-00977-1 · DOI
  193. Zheng, 2018, By activating Akt/eNOS bilobalide B inhibits autophagy and promotes angiogenesis following focal cerebral ischemia reperfusion, Cell. Physiol. Biochem., 47, 604, 10.1159/000490016 · DOI
  194. Yuan, 2017, Effects of artemisinin on expression of apoptosis-related factors and inflammatory mediators, Contemp. Med., 23, 23
  195. Mao, 2011, Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats, Brain Res., 1385, 275, 10.1016/j.brainres.2011.02.015 · DOI
  196. Ling, 2008, The protective effect of Chuanxiong Oil on focal cerehral reperfusion injury in rat, Pharmaco. Clin. Chin. Materia Medica., 24, 39
  197. Wei, 2017, Salidroside inhibits inflammation through PI3K/Akt/HIF signaling after focal cerebral ischemia in rats, Inflammation, 40, 1, 10.1007/s10753-017-0573-x · DOI
  198. Yin, 2010, Protective effect of astragaloside on focal cerebral Ischemia/Reperfusion injury in rats, Am. J. Chin. Med., 38, 517, 10.1142/S0192415X10008020 · DOI
  199. Yin, 2009, Effects of astragalosides on the expression of BDNF, TrkB and p75NTR mRNA against focal cerebral ischemia-reperfusion injury, Chin. Pharmacol. Bull., 25, 672
  200. Wu, 2014, Astragalosides attenuate learning and memory impairment in rats following ischemia reperfusion injury, Mol. Med. Rep., 9, 1319, 10.3892/mmr.2014.1969 · DOI

200 of 211 shown

Cited by

Sorted by citations

See all 151

Metadata

Authors
Long, Y., Yang, Q., Xiang, Y., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W.
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2020-09
Volume
159
Pages
104795
ISSN
1043-6618
DOI
10.1016/j.phrs.2020.104795
Cited by
151
References
8
Language
en
Licence
Funders
National Natural Science Foundation of China

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review